What Happened
The World Health Organization (WHO) has prequalified the first-ever malaria treatment for newborns and infants, a significant step forward in the fight against malaria. Meanwhile, in Utah, a medical board has called for the immediate suspension of a pilot program using AI to renew prescriptions. In other news, a global childhood vaccine campaign is expanding, and a woman has spoken out about using delivery apps to hide her alcoholism.
Malaria Breakthrough
The WHO's prequalification of artemether-lumefantrine, an antimalarial formulation designed specifically for newborns and young infants, is expected to expand access to quality-assured treatment for this vulnerable group. Until now, infants with malaria have been treated with formulations intended for older children, increasing the risk of dosing errors, side effects, and toxicity.
- Treatment gap: 30 million babies born each year are at risk of malaria
- Prequalification: ensures the medicine meets international standards of quality, safety, and efficacy
- Impact: will help close a long-standing treatment gap for newborns and young infants
Utah AI Doctor Experiment
A Utah pilot program using AI to renew prescriptions has faced backlash from the state's medical board, which has called for its immediate suspension. The program aimed to use a bot to renew prescriptions, but concerns have been raised about patient safety and the potential for errors.
What Went Wrong
- Lack of human oversight: the program relied solely on AI to make decisions
- Patient safety: concerns about the potential for errors and adverse reactions
- Regulatory issues: the program may not have met state regulations and guidelines
Childhood Vaccine Campaign
A global childhood vaccine campaign is growing, with new initiatives and partnerships being announced. The campaign aims to increase access to vaccines for children in developing countries and reduce the burden of preventable diseases.
- Partnerships: new collaborations between governments, NGOs, and private sector organizations
- Funding: increased investment in vaccine development and distribution
- Impact: expected to save millions of lives and prevent countless cases of disease
Personal Stories
A woman has spoken out about using delivery apps to hide her alcoholism. Hattie Underwood, a recovered alcoholic, told her story of using apps to "anonymise" her alcohol consumption and the dangers of relying on technology to cope with addiction.
"I was using delivery apps to get alcohol delivered to my doorstep, and it was just so easy and convenient... but it was also really isolating and lonely." — Hattie Underwood
What Comes Next
As the global health landscape continues to evolve, we can expect to see new developments in vaccine technology, AI in healthcare, and innovative approaches to addressing addiction and disease. Stay tuned for more updates and analysis on these and other health-related topics.
Key Facts
- WHO: prequalified artemether-lumefantrine for malaria treatment in newborns and infants
- Utah: medical board calls for suspension of AI doctor experiment
- Vaccine campaign: global initiative to increase access to childhood vaccines
What Happened
The World Health Organization (WHO) has prequalified the first-ever malaria treatment for newborns and infants, a significant step forward in the fight against malaria. Meanwhile, in Utah, a medical board has called for the immediate suspension of a pilot program using AI to renew prescriptions. In other news, a global childhood vaccine campaign is expanding, and a woman has spoken out about using delivery apps to hide her alcoholism.
Malaria Breakthrough
The WHO's prequalification of artemether-lumefantrine, an antimalarial formulation designed specifically for newborns and young infants, is expected to expand access to quality-assured treatment for this vulnerable group. Until now, infants with malaria have been treated with formulations intended for older children, increasing the risk of dosing errors, side effects, and toxicity.
- Treatment gap: 30 million babies born each year are at risk of malaria
- Prequalification: ensures the medicine meets international standards of quality, safety, and efficacy
- Impact: will help close a long-standing treatment gap for newborns and young infants
Utah AI Doctor Experiment
A Utah pilot program using AI to renew prescriptions has faced backlash from the state's medical board, which has called for its immediate suspension. The program aimed to use a bot to renew prescriptions, but concerns have been raised about patient safety and the potential for errors.
What Went Wrong
- Lack of human oversight: the program relied solely on AI to make decisions
- Patient safety: concerns about the potential for errors and adverse reactions
- Regulatory issues: the program may not have met state regulations and guidelines
Childhood Vaccine Campaign
A global childhood vaccine campaign is growing, with new initiatives and partnerships being announced. The campaign aims to increase access to vaccines for children in developing countries and reduce the burden of preventable diseases.
- Partnerships: new collaborations between governments, NGOs, and private sector organizations
- Funding: increased investment in vaccine development and distribution
- Impact: expected to save millions of lives and prevent countless cases of disease
Personal Stories
A woman has spoken out about using delivery apps to hide her alcoholism. Hattie Underwood, a recovered alcoholic, told her story of using apps to "anonymise" her alcohol consumption and the dangers of relying on technology to cope with addiction.
"I was using delivery apps to get alcohol delivered to my doorstep, and it was just so easy and convenient... but it was also really isolating and lonely." — Hattie Underwood
What Comes Next
As the global health landscape continues to evolve, we can expect to see new developments in vaccine technology, AI in healthcare, and innovative approaches to addressing addiction and disease. Stay tuned for more updates and analysis on these and other health-related topics.
Key Facts
- WHO: prequalified artemether-lumefantrine for malaria treatment in newborns and infants
- Utah: medical board calls for suspension of AI doctor experiment
- Vaccine campaign: global initiative to increase access to childhood vaccines